Gilteritinib as Bridging and Posttransplant Maintenance for Relapsed Acute Myeloid Leukemia with FLT3-ITD Mutation Accompanied by Extramedullary Disease in Elderly.
- DOI
- 10.1155/2023/7164742
- Published
- 2023
- Container
- Case reports in hematology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1155/2023/7164742,
title = {Gilteritinib as Bridging and Posttransplant Maintenance for Relapsed Acute Myeloid Leukemia with FLT3-ITD Mutation Accompanied by Extramedullary Disease in Elderly.},
author = {Saburi M and Sakata M and Maruyama R and Kodama Y and Takata H and Miyazaki Y and Kawano K and Wada J and Urabe S and Ohtsuka E},
year = {2023},
journal = {Case reports in hematology},
doi = {10.1155/2023/7164742},
url = {https://doi.org/10.1155/2023/7164742}
}RIS
TY - JOUR TI - Gilteritinib as Bridging and Posttransplant Maintenance for Relapsed Acute Myeloid Leukemia with FLT3-ITD Mutation Accompanied by Extramedullary Disease in Elderly. AU - Saburi M AU - Sakata M AU - Maruyama R AU - Kodama Y AU - Takata H AU - Miyazaki Y AU - Kawano K AU - Wada J AU - Urabe S AU - Ohtsuka E PY - 2023 JO - Case reports in hematology DO - 10.1155/2023/7164742 UR - https://doi.org/10.1155/2023/7164742 ER -
APA
M, S., M, S., R, M., Y, K., H, T., Y, M., K, K., J, W., S, U., & E, O. (2023). Gilteritinib as Bridging and Posttransplant Maintenance for Relapsed Acute Myeloid Leukemia with FLT3-ITD Mutation Accompanied by Extramedullary Disease in Elderly.. Case reports in hematology. https://doi.org/10.1155/2023/7164742
Source records
- pubmed · retrieved 2026-09-26T05:59:53.655Z